# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-012754
Filing Date
2024-02-08
Accepted
2024-02-08 16:05:34
Documents
65
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | onvo-20231231.htm iXBRL | 10-Q | 1777000
2 | EX-31.1 | onvo-ex31_1.htm | EX-31.1 | 12069
3 | EX-31.2 | onvo-ex31_2.htm | EX-31.2 | 12028
4 | EX-32.1 | onvo-ex32_1.htm | EX-32.1 | 9958
| Complete submission text file | 0000950170-24-012754.txt |  | 6636951

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | onvo-20231231.xsd | EX-101.SCH | 993185
66 | EXTRACTED XBRL INSTANCE DOCUMENT | onvo-20231231_htm.xml | XML | 967135

Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 24608991
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)